DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction
Clinical trial NCT03877237 · COMPLETED
Trial details
- NCT number
- NCT03877237
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-09
- Primary completion
- 2020-03-07
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.